CA2-话题@MedSci

#CA2#

33篇内容 | 936人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1602865, encodeId=680f1602865c2, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=NEJM：抗BDCA2抗体Litifilimab对系统性红斑狼疮的治疗作用（LILAC研究）, objectType=article, longId=738583, objectId=9adbe3858308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9adbe3858308, replyNumber=0, likeNumber=54, createdTime=2022-09-09, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9adbe3858308, moduleTitle=NEJM：抗BDCA2抗体Litifilimab对系统性红斑狼疮的治疗作用（LILAC研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9adbe3858308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602864, encodeId=8dc316028649b, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=NEJM：抗BDCA2抗体Litifilimab 治疗皮肤红斑狼疮有效和安全, objectType=article, longId=734182, objectId=530be341822b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=530be341822b, replyNumber=0, likeNumber=37, createdTime=2022-08-03, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=530be341822b, moduleTitle=NEJM：抗BDCA2抗体Litifilimab 治疗皮肤红斑狼疮有效和安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=530be341822b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602863, encodeId=a6b816028639c, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=SERCA2氧化还原C674的取代通过激活IRE1α/XBP1s通路促进肺血管重塑, objectType=article, longId=728536, objectId=cb03e28536fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb03e28536fc, replyNumber=0, likeNumber=33, createdTime=2022-06-04, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb03e28536fc, moduleTitle=SERCA2氧化还原C674的取代通过激活IRE1α/XBP1s通路促进肺血管重塑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb03e28536fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602862, encodeId=11431602862f9, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=J Invest Dermatol：口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究, objectType=article, longId=300170, objectId=b00e3001e032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b00e3001e032, replyNumber=0, likeNumber=46, createdTime=2022-03-08, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b00e3001e032, moduleTitle=J Invest Dermatol：口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b00e3001e032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602861, encodeId=f8a91602861e5, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=J Immunother Cancer：Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性：来自CA209-538临床研究, objectType=article, longId=220657, objectId=8c3622065e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c3622065e52, replyNumber=0, likeNumber=36, createdTime=2021-11-22, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c3622065e52, moduleTitle=J Immunother Cancer：Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性：来自CA209-538临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c3622065e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602860, encodeId=74f1160286003, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Nat Commun：BRCA1/BRCA2突变携带者的乳腺癌发病风险研究, objectType=article, longId=207488, objectId=3be820e4881c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be820e4881c, replyNumber=0, likeNumber=38, createdTime=2021-02-24, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be820e4881c, moduleTitle=Nat Commun：BRCA1/BRCA2突变携带者的乳腺癌发病风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be820e4881c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602859, encodeId=dee11602859e0, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Br J Cancer：携带BRCA2突变的乳腺癌患者的生存率分析, objectType=article, longId=207348, objectId=628320e3487c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=628320e3487c, replyNumber=0, likeNumber=47, createdTime=2021-02-21, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=628320e3487c, moduleTitle=Br J Cancer：携带BRCA2突变的乳腺癌患者的生存率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=628320e3487c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602858, encodeId=0cb41602858d7, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Nature Neuroscience: 海马CA2区社交新奇编码及其在22q11.2微缺失小鼠模型中的破坏和拯救, objectType=article, longId=204992, objectId=a9b4204992f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9b4204992f5, replyNumber=0, likeNumber=33, createdTime=2020-12-31, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9b4204992f5, moduleTitle=Nature Neuroscience: 海马CA2区社交新奇编码及其在22q11.2微缺失小鼠模型中的破坏和拯救, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9b4204992f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602857, encodeId=9b12160285eec, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Br J Cancer：ER表达状态对BRCA2突变型乳腺癌预后的影响, objectType=article, longId=201035, objectId=75fa201035f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75fa201035f9, replyNumber=0, likeNumber=50, createdTime=2020-09-23, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75fa201035f9, moduleTitle=Br J Cancer：ER表达状态对BRCA2突变型乳腺癌预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75fa201035f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602856, encodeId=af7c160285608, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Eur Urol：BRCA2基因组区域的前列腺癌风险评估 , objectType=article, longId=197246, objectId=6a7819e246ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a7819e246ad, replyNumber=0, likeNumber=35, createdTime=2020-07-10, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a7819e246ad, moduleTitle=Eur Urol：BRCA2基因组区域的前列腺癌风险评估 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a7819e246ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602855, encodeId=d279160285551, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Brit J Surg：BRCA1和/或BRCA2突变携带者大肠癌风险, objectType=article, longId=192509, objectId=e7681925097d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7681925097d, replyNumber=0, likeNumber=50, createdTime=2020-04-20, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7681925097d, moduleTitle=Brit J Surg：BRCA1和/或BRCA2突变携带者大肠癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7681925097d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602854, encodeId=d739160285436, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=英国NICE批准将PARP抑制剂Lynparza，用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者, objectType=article, longId=186454, objectId=6fbf186454dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fbf186454dd, replyNumber=0, likeNumber=33, createdTime=2020-01-19, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fbf186454dd, moduleTitle=英国NICE批准将PARP抑制剂Lynparza，用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fbf186454dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602853, encodeId=6cce160285353, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Biogen宣布BDCA2单抗BIIB059在皮肤性红斑狼疮和系统性红斑狼疮的2期研究阳性结果, objectType=article, longId=184168, objectId=6fdd184168d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fdd184168d5, replyNumber=0, likeNumber=38, createdTime=2019-12-06, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fdd184168d5, moduleTitle=Biogen宣布BDCA2单抗BIIB059在皮肤性红斑狼疮和系统性红斑狼疮的2期研究阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fdd184168d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602852, encodeId=72e8160285229, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Eur Urol：男性BRCA1和BRCA2变异位点携带者前列腺癌风险研究, objectType=article, longId=180269, objectId=8b7c18026916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b7c18026916, replyNumber=0, likeNumber=41, createdTime=2019-10-01, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b7c18026916, moduleTitle=Eur Urol：男性BRCA1和BRCA2变异位点携带者前列腺癌风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b7c18026916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602851, encodeId=eb5c1602851bd, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Circulation：心律失常性心肌病发生前的右心室Ca2+稳定失衡和连接蛋白43功能丧失, objectType=article, longId=179954, objectId=58501e99540c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58501e99540c, replyNumber=0, likeNumber=43, createdTime=2019-09-25, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58501e99540c, moduleTitle=Circulation：心律失常性心肌病发生前的右心室Ca2+稳定失衡和连接蛋白43功能丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58501e99540c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602850, encodeId=17131602850b0, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=JAMA Oncology: BRCA2或为非霍奇金淋巴瘤关键基因, objectType=article, longId=176438, objectId=091c1e6438af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=091c1e6438af, replyNumber=0, likeNumber=30, createdTime=2019-07-31, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=091c1e6438af, moduleTitle=JAMA Oncology: BRCA2或为非霍奇金淋巴瘤关键基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=091c1e6438af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602849, encodeId=2e66160284970, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Brit J Cancer：高度和体重指数与BRCA1和BRCA2突变携带者卵巢癌风险, objectType=article, longId=169031, objectId=f0df169031d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0df169031d5, replyNumber=0, likeNumber=29, createdTime=2019-06-25, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0df169031d5, moduleTitle=Brit J Cancer：高度和体重指数与BRCA1和BRCA2突变携带者卵巢癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0df169031d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602848, encodeId=0440160284823, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=J Dent Res：电动力流动增强F-, Ca2+, K+和Na+离子向釉质的传递, objectType=article, longId=159499, objectId=b8851594994c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8851594994c, replyNumber=0, likeNumber=0, createdTime=2019-02-06, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8851594994c, moduleTitle=J Dent Res：电动力流动增强F-, Ca2+, K+和Na+离子向釉质的传递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8851594994c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=功能性消化不良、脂肪肝、CA242增高，是怎么回事呢？, objectType=article, longId=159127, objectId=9d6815912e44, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d6815912e44, replyNumber=0, likeNumber=38, createdTime=2019-01-30, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d6815912e44, moduleTitle=功能性消化不良、脂肪肝、CA242增高，是怎么回事呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d6815912e44)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602846, encodeId=ce5a1602846fe, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Prostate Cancer P D：生殖细胞系BRCA2变异频率的增加与前列腺癌转移相关, objectType=article, longId=156538, objectId=cdc81565387c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdc81565387c, replyNumber=0, likeNumber=29, createdTime=2018-12-25, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdc81565387c, moduleTitle=Prostate Cancer P D：生殖细胞系BRCA2变异频率的增加与前列腺癌转移相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdc81565387c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CA2

2020-05-29

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

NEJM：抗BDCA2抗体Litifilimab对系统性红斑狼疮的治疗作用（LILAC研究）

2022-09-09

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

NEJM：抗BDCA2抗体Litifilimab 治疗皮肤红斑狼疮有效和安全

2022-08-03

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

SERCA2氧化还原C674的取代通过激活IRE1α/XBP1s通路促进肺血管重塑

2022-06-04

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

J Invest Dermatol：口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究

2022-03-08

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

J Immunother Cancer：Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性：来自CA209-538临床研究

2021-11-22

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Nat Commun：BRCA1/BRCA2突变携带者的乳腺癌发病风险研究

2021-02-24

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Br J Cancer：携带BRCA2突变的乳腺癌患者的生存率分析

2021-02-21

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Nature Neuroscience: 海马CA2区社交新奇编码及其在22q11.2微缺失小鼠模型中的破坏和拯救

2020-12-31

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Br J Cancer：ER表达状态对BRCA2突变型乳腺癌预后的影响

2020-09-23

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Eur Urol：BRCA2基因组区域的前列腺癌风险评估

2020-07-10

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Brit J Surg：BRCA1和/或BRCA2突变携带者大肠癌风险

2020-04-20

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

英国NICE批准将PARP抑制剂Lynparza，用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者

2020-01-19

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Biogen宣布BDCA2单抗BIIB059在皮肤性红斑狼疮和系统性红斑狼疮的2期研究阳性结果

2019-12-06

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Eur Urol：男性BRCA1和BRCA2变异位点携带者前列腺癌风险研究

2019-10-01

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Circulation：心律失常性心肌病发生前的右心室Ca2+稳定失衡和连接蛋白43功能丧失

2019-09-25

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

JAMA Oncology: BRCA2或为非霍奇金淋巴瘤关键基因

2019-07-31

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Brit J Cancer：高度和体重指数与BRCA1和BRCA2突变携带者卵巢癌风险

2019-06-25

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

J Dent Res：电动力流动增强F-, Ca2+, K+和Na+离子向釉质的传递

2019-02-06

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

功能性消化不良、脂肪肝、CA242增高，是怎么回事呢？

2019-01-30

TZF0810 (审核中...)

前往app查看评论内容

#CA2#

Prostate Cancer P D：生殖细胞系BRCA2变异频率的增加与前列腺癌转移相关

2018-12-25

科室
- - 订阅+
  - 更多科室
工具
服务